Recent studies have shown that in cancer cells, AXT can regulate ROS production, and its pro-oxidative features are linked to proapoptotic effects in cancer cells selectively while having antioxidative features linked to protective effects in nearby healthy cells [15]. This evidence concerns the gene CNTN2 and cancer.